Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01509079 · ClinicalTrials.gov registry record · Phase 2
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
A Phase 2 study, sponsored by HealthPartners Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 116
- Enrollment target
NCT01509079 is a Phase 2 study that has completed, run by HealthPartners Institute. The registered enrollment target is 116 participants.
The verdict
NCT01509079, a Phase 2 study, has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 116 participants
- Enrollment target
Study Summary
The Purpose of this study is to determine whether vitamin D3 supplements will decrease the muscle and bone pain that are reported by women who take Aromatase Inhibitors.
Interventions
- DRUG Vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01509079
The ClinicalTrials.gov registry entry for NCT01509079 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 is the first listed.
NCT01509079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01509079 about?
NCT01509079 is a clinical study titled "Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors". The Purpose of this study is to determine whether vitamin D3 supplements will decrease the muscle and bone pain that are reported by women who take Aromatase Inhibitors.
What is the current status of trial NCT01509079?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 116 participants. The study started on 2012-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01509079?
The interventions under investigation include: Vitamin D3 (DRUG).
Who is sponsoring clinical trial NCT01509079?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.